Tag: Corrective and preventive actions GMP

How to Ensure GMP Compliance for Pharmaceuticals Produced in the EU

February 6, 2025 digi

How to Ensure GMP Compliance for Pharmaceuticals Produced in the EU A Comprehensive Guide to GMP Compliance for Pharmaceutical Manufacturing in the EU Introduction to GMP Compliance in the EU Pharmaceutical manufacturing in the European Union (EU) is governed by stringent Good Manufacturing Practices (GMP) to ensure product quality, safety, and efficacy. Enforced by the…

GMP in Europe (EMA, MHRA)

The Impact of Schedule M Revised on Indian Pharmaceutical R&D and Drug Development

February 6, 2025 digi

The Impact of Schedule M Revised on Indian Pharmaceutical R&D and Drug Development How Schedule M Revised Influences Pharmaceutical R&D and Drug Development in India Introduction to Schedule M Revised and Its Relevance to R&D Research and Development (R&D) is the cornerstone of innovation in the pharmaceutical industry, driving the discovery and development of new…

GMP in India

How to Leverage Technology for GMP Compliance in Latin America

February 6, 2025 digi

How to Leverage Technology for GMP Compliance in Latin America A Step-by-Step Guide to Using Technology for GMP Compliance in Latin America Introduction to GMP Compliance and Technology Achieving Good Manufacturing Practices (GMP) compliance is essential for pharmaceutical manufacturers in Latin America, where regulatory frameworks like those established by ANVISA in Brazil and Cofepris in…

GMP in Emerging Markets (GCC, Latin America, Africa)

How to Maintain GMP Compliance During the Scaling-Up Process in Pharma Manufacturing

February 6, 2025 digi

How to Maintain GMP Compliance During the Scaling-Up Process in Pharma Manufacturing Expert Guide to Ensuring GMP Compliance in Pharmaceutical Scale-Up Processes Introduction to GMP Compliance in Scale-Up Scaling up pharmaceutical manufacturing involves transitioning from laboratory-scale production to commercial-scale operations. While this process is essential for meeting market demand, it presents unique challenges in maintaining…

GMP in Europe (EMA, MHRA)

Best Tools for Ensuring GMP Compliance in the GCC Pharmaceutical Sector

February 6, 2025 digi

Best Tools for Ensuring GMP Compliance in the GCC Pharmaceutical Sector Essential Tools for Achieving GMP Compliance in the GCC Pharmaceutical Industry Introduction to GMP Compliance in the GCC The Gulf Cooperation Council (GCC) region has seen significant growth in its pharmaceutical sector, driven by increased demand for high-quality medicines and stringent regulatory requirements. Achieving…

GMP in Emerging Markets (GCC, Latin America, Africa)

How Schedule M Revised Supports the Use of Automation and Technology in GMP Compliance

February 6, 2025 digi

How Schedule M Revised Supports the Use of Automation and Technology in GMP Compliance Enhancing GMP Compliance Through Automation and Technology Under Schedule M Revised Introduction to Automation, Technology, and Schedule M Revised The revised Schedule M under the Drugs and Cosmetics Rules, 1945, emphasizes Good Manufacturing Practices (GMP) to ensure the safety, efficacy, and…

GMP in India

How MHRA’s GMP Guidelines Apply to Clinical Trials and Drug Manufacturing

February 5, 2025 digi

How MHRA’s GMP Guidelines Apply to Clinical Trials and Drug Manufacturing A Step-by-Step Guide to MHRA’s GMP Guidelines for Clinical Trials and Drug Manufacturing Introduction to MHRA GMP Guidelines The Medicines and Healthcare products Regulatory Agency (MHRA) oversees the implementation of Good Manufacturing Practices (GMP) in the UK to ensure the safety, quality, and efficacy…

GMP in Europe (EMA, MHRA)

How to Implement a Quality Management System (QMS) for GMP Compliance in Emerging Markets

February 5, 2025 digi

How to Implement a Quality Management System (QMS) for GMP Compliance in Emerging Markets A Step-by-Step Guide to Implementing a QMS for GMP Compliance in Emerging Markets Introduction to QMS and GMP Compliance A Quality Management System (QMS) is the backbone of any successful pharmaceutical manufacturing operation, ensuring adherence to Good Manufacturing Practices (GMP). In…

GMP in Emerging Markets (GCC, Latin America, Africa)

How Schedule M Revised Supports GMP Compliance for Clinical Trials in India

February 5, 2025 digi

How Schedule M Revised Supports GMP Compliance for Clinical Trials in India A Guide to Ensuring GMP Compliance for Clinical Trials Under Schedule M Revised Introduction to Schedule M Revised and Clinical Trials Clinical trials are a critical phase in the development of pharmaceutical products, requiring stringent adherence to Good Manufacturing Practices (GMP) to ensure…

GMP in India

Best Practices for Preventing Cross-Contamination in GMP Pharmaceutical Facilities

February 5, 2025 digi

Best Practices for Preventing Cross-Contamination in GMP Pharmaceutical Facilities Effective Strategies to Prevent Cross-Contamination in GMP-Compliant Pharmaceutical Facilities Introduction to Cross-Contamination and GMP Cross-contamination in pharmaceutical manufacturing can compromise product quality, endanger patient safety, and result in regulatory non-compliance. To mitigate these risks, Good Manufacturing Practices (GMP), as enforced by regulatory bodies like the European…

GMP in Europe (EMA, MHRA)